Skip to main content
. Author manuscript; available in PMC: 2022 May 1.
Published in final edited form as: Gen Comp Endocrinol. 2021 Feb 4;305:113734. doi: 10.1016/j.ygcen.2021.113734

Table 3.

Results of paired t-tests examining effect of CBX treatment on GC-dependent gene expression in slice culture of hypothalamus (HYP), hippocampus (HP), caudal telencephalon (cTEL), and cerebellum (CER).

t(df) 95% CI [LL, UL] Cohen’s d P
HYP
SGK1 0.86(5) [−0.168, 0.337] 0.350 0.215
FKBP5 0.35(5) [−0.228, 0.299] 0.142 0.371
GILZ −1.74(5) [−0.166, 0.032] 0.712 0.071
MR 0.07 (5) [−0.341, 0.356] 0.036 0.948
GR 0.72(5) [−0.078, 0.139] 0.296 0.502
HP
SGK1 −0.89(4) [−0.593, 0.306] 0.397 0.213
FKBP5 1.15(4) [−0.118, 0.284] 0.513 0.158
GILZ 1.46(4) [−0.037, 0.118] 0.652 0.109
MR −0.94(4) [−0.296, 0.146] 0.420 0.401
GR −0.54(3) [−0.026, 0.018] 0.271 0.625
cTEL
SGK1 −0.95(5) [−0.294, 0.136] 0.386 0.194
FKBP5 −1.31(5) [−0.153, 0.050] 0.536 0.124
GILZ −0.53(3) [−0.354, 0.252] 0.267 0.315
MR 0.35(5) [−0.053, 0.070] 0.144 0.738
GR 1.84(5) [−0.016, 0.098] 0.751 0.125
CER
SGK1 0.54(5) [−0.425, 0.648] 0.218 0.308
FKBP5 0.72(4) [−0.192, 0.327] 0.322 0.256
GILZ 0.37(5) [−0.117, 0.157] 0.152 0.363
MR −1.51(5) [−0.394, 0.102] 0.617 0.191
GR −2.15(5) [−0.385, 0.034] 0.877 0.084